Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Zoonotic & Vector-borne Diseases specialty page provides zoonotic & vector-borne disease-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


New POC Test for Zika Virus Awarded Conditional LTA from UNICEF
Chembio Diagnostics, Inc.’s DPP Zika System, was recently awarded a conditional Long-Term Arrangement (LTA) for purchasing from the United Nations Children's Fund (UNICEF), once the company satisfies certain conditions.
New Research Looks at Zika Virus Immune Response and Chloroquine as Treatment Option
Two new studies are providing some additional insight and hope for treating the effects of the Zika virus.
Top 5 <i>Contagion</i>® News Articles for the Week of November 12, 2017
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Study Suggests Naturally-Acquired Immunity Against Zika Virus May Already Occur
The results of a new study suggest that naturally-acquired immunity against the Zika virus may already occur in women in endemic regions of the world.
Tuberculosis Susceptibility Has Genetic Basis
Researchers are gaining a greater understanding of the role that human genetics plays in determining who contracts tuberculosis as well as how severely it impacts its victims.
The latest WHO External Situation Report suggests that the plague outbreak that has been ravaging Madagascar for months may finally be winding down.
Congress Pushes for Predictive Models for Zika and Other Infectious Disease Outbreaks: Public Health Watch
Congress has requested more information about how government agencies are currently using predictive modeling and simulation technologies to assess the country’s risk for outbreaks and prepare responses.
Improving Diagnosis of Lyme Disease: Laboratory and Clinical Approaches
Contagion® Peer Exchange panelists discuss the challenge in diagnosing Lyme disease and new technologies that can improve testing.
Big advances in treatment can